Bucladesine hemicalcium

(Synonyms: Dibutyryl cAMP hemicalcium; DBcAMP hemicalcium)
49 Cited Publications
Customer Review

Based on 49 publication(s) in Google Scholar

Bucladesine (Dibutyryl cAMP; DBcAMP) hemicalcium is a membrane-permeable 3′, 5′-cyclic adenosine monophosphate (cAMP) analog. Bucladesine selectively activates cAMP dependent protein kinase (PKA) by increasing the intracellular level of cAMP. Bucladesine significantly attenuates MDMA-induced increases in hippocampal mitochondrial ROS formation, mitochondrial outer membrane damage, cytochrome c release, and hippocampal ADP/ATP ratio, thereby improving spatial learning and memory impairments. Bucladesine exhibit anti-nociceptive and anti-inflammation effect. Bucladesine can inhibit cancer cells proliferation, induce apoptosis. Bucladesine can be used for the researches of neurological disease, cancer, inflammation.

For research use only. We do not sell to patients.

  • Purity: 98.58%
  • CAS No.: 938448-87-4
  • Formula: C18H24N5O8P·1/2Na
  • Molecular Weight:489.43
  • Storage:

    4°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Bucladesine hemicalcium

More
Customer Validation & Images
WBCell Proliferation/Viability Assay
  • WB
  • WB
  • WB
  • Cell Proliferation/Viability Assay
  • Cell Proliferation/Viability Assay

All PKA Isoforms

More
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00